Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Almudena Gomez-Guiu"'
Autor:
Belen Sadaba, Anabel del Barrio, Miguel Angel Campanero, Jose Ramon Azanza, Almudena Gomez-Guiu, Jose Maria Lopez-Picazo, Salvador Martin Algarra, Francisco Guillén Grimá, Maria Blanco Prieto, Jose Luis Perez-Gracia, Alfonso Gurpide
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89747 (2014)
Palonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never been studied, even though it co
Externí odkaz:
https://doaj.org/article/732bd83ce7fe475ebabe0fd50f2fd1e3
Publikováno v:
Revista Iberoamericana de Micología. 31:255-261
The treatment of invasive aspergillosis requires the use of drugs that characteristically have complex pharmacokinetic properties, the knowledge of which is essential to achieve maximum efficacy with minimal risk to the patient. The lipid-based ampho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6001add9dfbd7576bd4feca9bafb220
https://doi.org/10.1016/j.riam.2014.05.001
https://doi.org/10.1016/j.riam.2014.05.001
Publikováno v:
Journal of Oncology Pharmacy Practice. 21:370-376
Complete monoclonal IgG antibodies which are in use in clinical practice share some pharmacological properties resulting in high concentrations in plasma. This fact is reflected in their low volumes of distribution, which can also be correlated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8904b3ad348c6c476e26733a5ec587
https://doi.org/10.1177/1078155214538085
https://doi.org/10.1177/1078155214538085
Autor:
Almudena Gomez-Guiu, Belén Sádaba, Ana Isabel Jimenez, María Victoria González, Javier Zarranz, Covadonga Pañeda, Veronica Ruz, Javier Moreno-Montañés
Publikováno v:
Molecular Therapy. 22:226-232
The objective of this study was to evaluate ocular tolerance, safety, and effect on intraocular pressure (IOP) of a topically administered small interfering RNA; SYL040012, on healthy volunteers. The study was an open-label, controlled, single-center
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186de7cd185512d35c6b35cce8ea4d1f
https://doi.org/10.1038/mt.2013.217
https://doi.org/10.1038/mt.2013.217
Publikováno v:
Clinical Drug Investigation. 33:375-381
Bilastine (Bilaxten™) is a novel non-sedating H1 receptor antagonist (antihistamine) developed in the dosage form of oral tablets and indicated for the treatment of allergic rhinitis (seasonal and perennial) and urticaria. Several clinical trials h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9395eda274c8e227dac2783b4d99dca9
https://doi.org/10.1007/s40261-013-0076-y
https://doi.org/10.1007/s40261-013-0076-y
Autor:
José Ramón Azanza, Almudena Gomez-Guiu, Salvador Martin Algarra, Jose Luis Perez-Gracia, Anabel del Barrio, Miguel Angel Campanero, María J. Blanco Prieto, José María López-Picazo, Francisco Guillén Grima, Alfonso Gurpide, Belén Sádaba
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 2, p e89747 (2014)
PLoS ONE, Vol 9, Iss 2, p e89747 (2014)
Background Palonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never been studied, even t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94fef6b38e94d9dd05417b2eaa28a65a
https://pubmed.ncbi.nlm.nih.gov/24587006
https://pubmed.ncbi.nlm.nih.gov/24587006
Autor:
María E. Zudaire, A. Manubens, A. Del Barrio, Belén Sádaba, Miguel Angel Campanero, Alfonso Gurpide, Almudena Gomez-Guiu, José María López-Picazo, José Ramón Azanza, Jose Luis Perez-Gracia
Publikováno v:
ResearcherID
e19514 Background: 5-HT3 antagonists are one of the mainstays of antiemetic treatment and they are available for intravenous (IV) or oral use. However, these routes cannot be used in patients with ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::897161441ea2dc5556cc179c453f64f5
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000208852001587&KeyUID=WOS:000208852001587
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000208852001587&KeyUID=WOS:000208852001587
Autor:
Sadaba, Belen1 bsadaba@unav.es, del Barrio, Anabel2, Campanero, Miguel Angel1, Azanza, Jose Ramon1, Gomez-Guiu, Almudena1, Lopez-Picazo, Jose Maria2, Algarra, Salvador Martin2, Grimá, Francisco Guillén3, Prieto, Maria Blanco4, Perez-Gracia, Jose Luis2, Gurpide, Alfonso2
Publikováno v:
PLoS ONE. Feb2014, Vol. 9 Issue 2, p1-5. 5p.